Natural killer cell tolerance: control by self or self-control?

A major challenge for the immune system is to control pathogens and stressed cells, such as infected or tumors cells, while sparing healthy self-cells. To achieve this tolerance to self, immune cells must recognize and differentiate "self" versus "nonself" and "self" versus "altered self." In the absence of self-tolerance, cells of the adaptive immune system attack healthy cells and cause autoimmune diseases such as lupus, psoriasis, and type I diabetes. Mechanisms at work to ensure tolerance in the innate immune system are still poorly understood. Natural killer cells are innate immune lymphocytes, which have the capacity to kill cellular targets and produce cytokines without prior specific sensitization. Because of these intrinsic effector capacities, tolerance mechanisms must exist to prevent autoreactivity. Herein, we will review the present knowledge on NK cell tolerance.

[1]  Baptiste N. Jaeger,et al.  Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance , 2011, Science Signaling.

[2]  Ernesto Merino,et al.  Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells , 2011, The Journal of cell biology.

[3]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[4]  F. Vély,et al.  Natural killer cells in human autoimmune diseases , 2010, Immunology.

[5]  D. Raulet,et al.  Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment , 2010, The Journal of experimental medicine.

[6]  W. Yokoyama,et al.  MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment , 2010, The Journal of experimental medicine.

[7]  Y. Dor,et al.  The activating receptor NKp46 is essential for the development of type 1 diabetes , 2010, Nature Immunology.

[8]  S. Jonjić,et al.  Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. , 2009, Immunity.

[9]  É. Vivier,et al.  Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo , 2009, Proceedings of the National Academy of Sciences.

[10]  É. Vivier,et al.  NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model 1 , 2009, The Journal of Immunology.

[11]  P. Brodin,et al.  NK cell education: not an on-off switch but a tunable rheostat. , 2009, Trends in immunology.

[12]  G. Leclercq,et al.  A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. , 2009, Immunity.

[13]  Sofia Johansson,et al.  The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. , 2009, Blood.

[14]  Joseph C. Sun,et al.  Cutting Edge: Viral Infection Breaks NK Cell Tolerance to “Missing Self”1 , 2008, The Journal of Immunology.

[15]  P. Brodin,et al.  Beyond licensing and disarming: A quantitative view on NK‐cell education , 2008, European journal of immunology.

[16]  Liping Yang,et al.  Continuous engagement of a self-specific activation receptor induces NK cell tolerance , 2008, The Journal of experimental medicine.

[17]  Joseph C. Sun,et al.  Tolerance of NK cells encountering their viral ligand during development , 2008, The Journal of experimental medicine.

[18]  Lewis L Lanier,et al.  Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.

[19]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[20]  É. Vivier,et al.  Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. , 2008, Blood.

[21]  J. Klein,et al.  Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. , 2007, Blood.

[22]  W. Yokoyama,et al.  Licensing of natural killer cells by self‐major histocompatibility complex class I , 2006, Immunological reviews.

[23]  D. Middleton,et al.  Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.

[24]  D. Raulet Missing self recognition and self tolerance of natural killer (NK) cells. , 2006, Seminars in immunology.

[25]  W. Yokoyama,et al.  How do natural killer cells find self to achieve tolerance? , 2006, Immunity.

[26]  A. Hayday,et al.  Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance , 2005, Nature Immunology.

[27]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[28]  R. Vance,et al.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.

[29]  P. Parham MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.

[30]  Eric Vivier,et al.  Natural Killer Cell Signaling Pathways , 2004, Science.

[31]  Christophe Benoist,et al.  Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Zimmer,et al.  Cis association of Ly49A with MHC class I restricts natural killer cell inhibition , 2004, Nature Immunology.

[33]  J. Ortaldo,et al.  NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. , 2003, Blood.

[34]  D. F. Barber,et al.  Vav1 Phosphorylation Is Induced by β2 Integrin Engagement on Natural Killer Cells Upstream of Actin Cytoskeleton and Lipid Raft Reorganization , 2003, The Journal of experimental medicine.

[35]  J. Zimmer,et al.  Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. , 2002, Blood.

[36]  W. Murphy,et al.  Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. , 2001, Blood.

[37]  W. Fridman,et al.  Molecular Basis of the Recruitment of the SH2 Domain-containing Inositol 5-Phosphatases SHIP1 and SHIP2 by FcγRIIB* , 2000, The Journal of Biological Chemistry.

[38]  J. Dorfman,et al.  Acquisition of Ly49 Receptor Expression by Developing Natural Killer Cells , 1998, The Journal of experimental medicine.

[39]  J. Zimmer,et al.  Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) , 1998, The Journal of experimental medicine.

[40]  J. Dorfman,et al.  The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. , 1997, Journal of Immunology.

[41]  C. Bieberich,et al.  Natural Killer Cell Tolerance in Mice with Mosaic Expression of Major Histocompatibility Complex Class I Transgene , 1997, The Journal of experimental medicine.

[42]  D. Raulet,et al.  Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. , 1997, Journal of immunology.

[43]  P. Parham,et al.  Killer cell receptors: keeping pace with MHC class I evolution , 1997, Immunological reviews.

[44]  D. Marguet,et al.  Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. , 1996, Journal of immunology.

[45]  R. Welsh,et al.  NK cell response to viral infections in beta 2-microglobulin-deficient mice. , 1995, Journal of immunology.

[46]  H. Ljunggren,et al.  Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Jaenisch,et al.  MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. , 1991, Science.

[48]  R. Jaenisch,et al.  Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice , 1991, Nature.

[49]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[50]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[51]  D. Margulies,et al.  Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. , 2002, Annual review of immunology.

[52]  W. Murphy,et al.  NK inhibitory-receptor blockade for purging of leukemia: effects on hematopoietic reconstitution. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[53]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[54]  K. Tadokoro,et al.  Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). , 1999, Human immunology.

[55]  Eric O Long,et al.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.